DGAP-Adhoc: DÃ¼rr AG secures 75.8% of the voting rights

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jul 15, 2014 at 9:45 AM

DGAP-Adhoc: DÃ¼rr AG secures 75.8% of the voting rights and 53.7% of the shares of HOMAG Group AG and announces a takeover offer to acquire the remaining shares

DÃ¼rr Aktiengesellschaft / Key word(s): Acquisition 15.07.2014 15:27 Dissemination of an Ad hoc announcement according to Â§ 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Bietigheim-Bissingen, July 15, 2014 - DÃ¼rr AG, via its wholly-owned subsidiary DÃ¼rr Technologies GmbH, has reached agreement with several major shareholders of HOMAG Group AG (HOMAG) to acquire a total of 53.7% of HOMAG shares. Purchase contracts are in place with Deutsche Beteiligungs AG (39.5% of shares), the Schuler/Klessmann share pool (3%) and two further shareholders (approx. 11%). The execution of the purchase contracts is subject to approval by the relevant antitrust authorities. The purchase price for the 53.7% of the HOMAG shares is EUR 219 million. An agreement was also reached with the Schuler family and the Klessmann foundation, who have so far held a 25.1% stake in HOMAG in the form of a share pool, on DÃ¼rr joining the pool. This relates to the 3% of HOMAG shares acquired from the pool and will be effective shortly before the execution of the purchase contract with the Schuler/Klessmann share pool. The share pool will consent to the completion of a control and/or profit and loss transfer agreement by DÃ¼rr. DÃ¼rr can exercise a total of 75.8% of the votes for that purpose. In total, the number of HOMAG shares amounts to 15,688,000. DÃ¼rr will submit a voluntary public takeover offer to the HOMAG shareholders pursuant to Sections 29 and 34 of the German Securities Acquisition and Takeover Act (WpÃG) to acquire all of the shares. DÃ¼rr Technologies GmbH has today published its decision to submit the takeover offer pursuant to Section 10 of the German Securities Acquisition and Takeover Act. The price DÃ¼rr offers to the free shareholders of HOMAG Group AG is EUR 26.35 per share payable in cash. The offer is thus 13.1% above the volume-weighted average XETRA price of the share based on the last three months (EUR 23.30, source: Bloomberg). The takeover bid is subject to certain conditions, in particular the approval by the relevant antitrust authorities. A squeeze-out or delisting of the HOMAG stock is not intended. HOMAG Group AG is to continue operating as an independent division under the HOMAG brand within the DÃ¼rr Group. As at the end of March 2014, the DÃ¼rr Group had EUR 867 million in available liquidity, including the proceeds from the bond placed at the end of March 2014. DÃ¼rr can therefore finance the acquisition with its own funds. The acquisition is to expand DÃ¼rr's portfolio in mechanical and plant engineering and provide new opportunities for growth. HOMAG has successfully initiated strategic measures to achieve growth and increase the company's value in the last few years. These measures will be continued and stepped up in close cooperation with DÃ¼rr. Positive effects are expected, among other things, through globalized value added and optimized processes and IT, as well as in the area of purchasing. HOMAG is a world-leading manufacturer of plant and machinery for the woodworking industry. The company operates worldwide and holds an estimated 28% share of the world market. In the fields of furniture manufacturing, structural elements and timber frame house construction, HOMAG offers perfectly aligned solutions, from the stand-alone machine through to the complete production line. HOMAG has seen a positive development in the last few years. In 2013 it achieved sales of EUR 789 million and an EBIT margin of 4.4%, with around 5,100 employees. Its equity ratio was 33%. DÃ¼rr is a mechanical and plant engineering group that holds leading positions in the world market in its areas of operation. It generates a good 80% of its sales in business with the automotive industry. It also supplies the aircraft, machinery, chemical and pharmaceutical industries with innovative production and environmental technology. DÃ¼rr has 54 business locations in 26 countries worldwide and employs approximately 8,250 staff. In 2013 DÃ¼rr achieved sales of EUR 2.4 billion and an EBIT margin of 8.4%. Its equity ratio was 26%. Important note: This announcement is neither an offer to buy nor an invitation to submit an offer to sell shares of HOMAG Group AG. The final terms of the takeover offer as well as further conditions relating to the takeover offer will be announced in the offer document following the approval of the publication of the offer document by the Federal Financial Services Supervisory Authority (Bundesanstalt fÃ¼r Finanzdienstleistungsaufsicht). Investors and holders of shares of HOMAG Group AG are strongly advised to read the offer document as well as any other documents relating to the offer as soon as they are published, as they contain important information. 15.07.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: DÃ¼rr Aktiengesellschaft Carl-Benz-Str. 34 74321 Bietigheim-Bissingen Germany Phone: 07142 78-1785 Fax: 07142 78-1716 E-mail: investor.relations@durr.com Internet: www.durr.com ISIN: DE0005565204, DE000A1EWGX1, XS1048589458 WKN: 556520, A1EWGX, A1YC44 Indices: MDAX Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart; Freiverkehr in Berlin, DÃ¼sseldorf, Hamburg, Hannover, MÃ¼nchen End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Portillo's Faces Class Action: Investor Losses at Stake

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

D-Wave Quantum Hit with Securities Fraud Lawsuit

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Layne's Chicken Fingers Expands with Brownsville Opening

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Championing Change: USTA Mid-Atlantic Gala's Impact

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...